Adhesive small bowel obstruction
– The fifth Dutch Snapshot study –
Adhesive small bowel obstruction is one of the most common indications for emergency abdominal surgery.1, 2 Most of these adhesions have developed after previous elective surgery. Over 1 in 5 patients undergoing abdominal surgery experiences at least 1 episode of ASBO in the 10 years following initial operation.3 Mean length of hospital stay for an episode of ASBO is 8 days, in-hospital mortality rates are up to 2.5%.4 Despite the high incidence and morbidity of ASBO, diagnosis and treatment of an episode of ASBO varies greatly between hospitals and even between doctors. Until now, optimal treatment patterns are unknown.
The objective of this study is to analyze practice variation in diagnosis and treatment in all patients admitted with suspected ASBO. The collected data will be used to generate new hypothesis on the optimal ideal diagnostic and therapeutic workflow based on best practices, and development of guidelines.
Prospective data registration of patients with a suspicion of ASBO.
All patients with a suspicion of ASBO, older than 17 years, can be included in the present snapshot study. This includes patients directly admitted for the surgery department, or patients admitted to other departments in which a surgical consultation is requested. Patients with an episode of small bowel obstruction with a definitive diagnosis other than adhesions fall outside of the scope of this study (eg. tumor as cause of SBO); patients with uncertain cause of bowel obstruction in which adhesions are considered in differential diagnosis are eligible.
Results from mapping of practice variation in diagnosis and treatment of a patient with an episode of ASBO. The final aim is to optimize care for all patients with a diagnosis of ASBO.
All Dutch hospitals are approached to participate in the nationwide snapshot study for ASBO. The first hospitals have started including patients, all participating hospitals will start between the 1st of May and the 1st of December 2019. For a period of 6 months patients will be included in the study. First results of this study are anticipated in July 2020.